Improvement of bone defect healing in rats via mesenchymal stem cell supernatant

• Published in: Experimental and therapeutic medicine Vol. 15; no. 2; pp. 1500 - 1504
• Main Authors: Zhou, Wanshan, Liu, Qian, Xu, Bo
• Format: Journal Article
• Language: English
• Published: Greece Spandidos Publications 01.02.2018; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Apoptosis; Bone diseases; Bone marrow; Care and treatment; Cytokines; Defects; Health aspects; Hydroxyapatite; Osteoporosis; Physiological aspects; Polyclonal antibodies; Proteins; Rats; Stem cells; Studies; Umbilical cord; United States > US; China; relative expression level; repair; stem cell supernatant; bone defect; mesenchymal stem cells
• ISSN: 1792-0981; 1792-1015
• DOI: 10.3892/etm.2017.5534

The effects of mesenchymal stem cells (MSCs) from three different sources in the treatment of bone defect with stem cells, and the differences of curative effects were studied. The umbilical cord, adipose and bone marrow mesen-chymal stem cells (BMSCs) of Sprague-Dawley (SD) rats were isolated and extracted, and the phenotype was identified for the 4th generation. The SD rat model of bone defect was established. The rats were randomly divided into: Normal saline group, umbilical cord mesenchymal stem cell (UMSC) group, adipose mesenchymal stem cell (AMSC) group and BMSC group. Rats were treated with tail intravenous injection, followed by radiological examination. The relative expression levels of factors bone morphogenetic protein-2 (BMP-2), osteocalcin (OCN), alkaline phosphatase (ALP), sclerostin (SOST), collagen carboxy-terminal telopeptide (CTX) and tartrated resistant acid phosphatase (TRACP) were measured via fluorescence quantitative PCR and western blotting. Among the three different kinds of stem cell supernatant, the detection using bicinchoninic acid (BCA) method showed that the content of P4-generation new cytokines was the highest. Wound healing in the three stem cell supernatant groups was significant at 3 weeks after operation, which was faster than that in DF12 control group; the expression levels of BMP-2, OCN and ALP in the bone samples treated with three kinds of MSC supernatants after 5 weeks were significantly increased compared with those in control group. The expression levels of SOST, CTX and TRACP were significantly decreased compared with those in control group. Three kinds of MSC supernatants can promote the bone regeneration through promoting the secretion of relatively more osteoblast factors, and inhibit the bone loss. The concentration of cytokines in UMSC supernatant was the highest under the same culture condition, and BMSC supernatant has a better effect in improving the bone defect repair of rats under the same concentration of cytokines.